Built for inflammatory skin diseases. Beginning with atopic dermatitis.
NellaDerm’s precision technology is designed around shared and condition-specific biological variability, creating a pathway that can expand across multiple inflammatory skin diseases.
Advancing Atopic Dermatitis Research at NellaDerm
NellaDerm Products are thoughtfully formulated to soothe sensitive and eczema-prone skin, offering immediate comfort and hydration. While it’s a reliable option for managing eczema-prone skin and flare-ups, our journey doesn’t stop there. Every day, our team is dedicated to advancing research and developing smarter, more effective treatments that aim to bring meaningful relief and a better quality of life for those living with eczema.
By choosing NellaDerm, you’re not only taking care of your skin today, but you’re supporting a future where eczema relief is more effective, and life feels a little easier.
At NellaDerm, we are dedicated to transforming the way atopic dermatitis is managed through cutting-edge, safe, and effective solutions grounded in science and technology. Founded on a commitment to evidence-based innovation, our mission is to develop steroid-free therapies that support long-term skin healing without compromising safety, especially for individuals suffering from chronic, relapsing skin inflammation.
Our research efforts span formulation science, dermal delivery systems, and AI-assisted personalized management tools, positioning NellaDerm as a unique bridge between AI, biomedical research, and next-generation dermatology technologies.
A New Paradigm in AD Care
Topical corticosteroids remain the most commonly prescribed treatment for eczema, but long-term use is associated with adverse effects, including skin thinning, rebound flare-ups, and systemic absorption risks, especially in children.
At NellaDerm, we are developing a new class of non-steroidal topical formulations that focus on barrier restoration, inflammation modulation, and flare prevention. Our product development is grounded in:
Bioactive compounds with clinically supported anti-inflammatory and skin-calming effects.
Advanced excipient technologies that ensure stability, penetration, and user compliance.
Skin barrier science, incorporating moisturizers and lipid-replenishing systems.
Our R&D Research
– Delivery systems
One of our core research focus areas is the development of advanced delivery systems that can target active ingredients deep into the skin layers, ensuring high efficacy with minimal irritation.
Led by Dr. Janfaza, our scientific team is exploring multiple dermal delivery platforms, including:
Nanoparticle-based systems
Hydrogel and liposomal carriers to enhance penetration and release profiles.
Bioadhesive delivery matrices for extended skin contact.
These technologies aim to overcome the limitations of conventional creams and ointments, ensuring the actives reach the stratum corneum and beyond, where eczema-related inflammation and barrier dysfunction originate.
– AI-Powered Personalized Atopic Dermatitis Management
In parallel with our topical research, NellaDerm is also working on the development of a first-of-its-kind AI-powered platform for eczema care, designed to:
Track triggers (diet, stress, weather, allergens) through smart data integration.
Personalize treatment recommendations based on user symptoms, history, and skin response.
Predict flare-ups using real-time analysis and machine learning models.
This platform will empower both patients and dermatologists by offering decision support tools tailored to each individual’s journey. We aim to move beyond one-size-fits-all care by incorporating data-driven personalization into eczema treatment and prevention.
Learn more at: www.myeczema.app
Backed by World-Class Technical Excellence
Our platform is built and continuously improved by a dedicated team of AI specialists, dermatology experts, and software engineers committed to transforming eczema care through technology.
AI & Machine Learning
Advanced algorithms trained on thousands of eczema cases for accurate predictions and personalized insights
Medical Expertise
Guidance from dermatology specialists ensuring all recommendations are clinically sound and evidence-based
Software Engineering
Robust, secure, and scalable infrastructure ensuring reliable performance and data protection
While Others Guess, We Measure.
Research, Publications, and Patents
Our team has an established track record in biomedical engineering, drug delivery, and skin barrier research, with a portfolio of peer-reviewed publications, conference presentations, and patent filings in these fields.
Our scientific team has published extensively on topics such as biomaterials for dermatological applications, transdermal drug delivery, and inflammation modulation.
Selected Publications:
– Janfaza et al. Next-Generation Atopic Dermatitis Treatments Based on Nanotechnology as an Effective and Low-Side-Effect Solution, Oxford Material Science, 2025
-Janfaza, S., & Razavi, S., Lipid-based nanoformulations for treatment of skin diseases. Nanotechnology Applied to Pharmaceutical Technology (pp. 247–266).
🔍 NellaDerm Innovation + delivery system
Selected Peer-Reviewed Publications:
1. Razavi, H., et al. “The Role of Artificial Intelligence in Atopic Dermatitis Research and Management.” Academia.edu.
2. Ebrahimian, K., et al. “Next-Generation Atopic Dermatitis Treatments Based on Nanotechnology as an Effective and Low-Side-Effect Solution.” Oxford Open, 2026.
Read the full article.
3. Emtenani, et al. AI-Powered Dermatology: Revolutionizing Skin Health Through Artificial Intelligence. Springer Nature, 2026.
Read the full publication:
If you’re interested in collaborating, have questions, or want to learn more about our research, we’d love to hear from you.
Reach out to us at: admin@nelladerm.com